Editorial Board

map


EDITOR-IN-CHIEF
 
Josef Köhrle
Charité, Universitätsmedizin Berlin, Germany
Prof Köhrle is University Professor of Molecular Endocrinology, Chairman of the Institute for Experimental Endocrinology and Scientific Director of the Charité Center for Therapeutic Research. He served as president of the European Thyroid Association (ETA). His primary research focus is on biosynthesis, transport, uptake, binding, metabolism and action of thyroid hormones and their metabolites with a focus on energy metabolism and regulation of body weight. Additional areas of interest include effects of endocrine disruptors and plant-derived secondary metabolites on the thyroid hormone axis as well as the role of trace elements and selenoproteins in the endocrine system.

 

STRATEGIC EDITORS
 
European Society of Endocrinology
Beata Kos-Kudła
Medical University of Silesia, Poland
Prof Beata Kos-Kudla is Chair of the the Department of Pathophysiology and Endocrinology, Division of Endocrinology and Neuroendocrine Tumors at the Medical University of Silesia in Katowice, Poland. She is a specialist in internal medicine, endocrinology, and nuclear medicine. Her scientific interests focus on clinical and experimental endocrinology. She is an advocate for true and extensive interdisciplinary scientific cooperation among all neuroendocrine tumour (NET) specialists in order to boost rapid development of this discipline. She founded the Polish Network of Neuroendocrine Tumors and the Polish National Register of NETs. She is President Elect of the Polish Society of Endocrinology, member of Executive Board of the European Society of Endocrinology and a member of the Advisory Board of the European Neuroendocrine Tumor Society (ENETS). She is also Editor-in-Chief of the Polish Journal of Endocrinology.
Society for Endocrinology
Jeremy Tomlinson
Oxford University, UK
Jeremy Tomlinson is currently Professor of Metabolic Endocrinology at the Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford. Alongside his clinical work as a consultant endocrinologist, his research explores the role of steroid hormones and their metabolism in the pathogenesis of common diseases including diabetes, PCOS and non-alcoholic fatty liver disease. He sits on the clinical committee of the Society for Endocrinology (SfE), is a convenor for the SfE adrenal and cardiovascular network and was elected to the SfE council in 2016.
Endocrinology of Chronic Disease
Richard Feelders
Erasmus Medical Center, Rotterdam, the Netherlands
Richard Feelders trained in Internal Medicine at the Maasstad Hospital, Rotterdam and the Erasmus Medical Center, Rotterdam (1993-1999), followed by an endocrinology fellowship, also at the Erasmus Medical Center (1999–2001). In 1999 Dr Feelders completed his thesis on endocrine changes in the acute phase response. In Erasmus Medical Center he is director of the Endocrinology training program, chair of the Pituitary and Adrenal Center Rotterdam and coordinator of the ENETS GEP-Neuroendocrine Tumor Center Rotterdam. In 2012–2013 Dr Feelders worked as Visiting Professor at the National Institutes of Health, Bethesda, USA.
Endocrinology of the Nervous System and Behaviour
Eric Fliers
University of Amsterdam, Netherlands
Professor of Endocrinology at the University of Amsterdam, serving as head of the Department of Endocrinology and Metabolism at the Academic Medical Center in Amsterdam. After receiving a PhD in Neuroscience he was trained as an internist-endocrinologist. Eric Fliers was one of the founders of the Netherlands Brain Bank. He served as chair of the Dutch Endocrine Society from 2013 until 2016. Eric Fliers was awarded the 2016 Novo Nordisk Award for Endocrinology for his scientific work in the field of thyroidology and neuroendocrinology.
Endocrine-Disrupting Chemicals
Barbara Demeneix
National Natural History Museum, France
Professor of Physiology in the National Natural History Museum in France. Trained in the United Kingdom, France, Canada, and Germany, she is an internationally recognised expert on thyroid function and the author of more than 160 scientific publications. She has received numerous awards for her work, notably the Nature Mentoring Award in 2011 and the CNRS Medal for Innovation in 2014. She is also active with many international committees addressing thyroid hormone and endocrine disruption (OECD, European Thyroid Association, etc).
Adrenal
Jérôme Bertherat
Paris Descartes University, France
Professor of Endocrinology serving as head of the Endocrinology Department at Cochin Hospital in Paris and coordinator of the national reference center for Rare Adrenal Diseases. He chairs the clinical committee of the European Society of Endocrinology. His research focus on cortisol disorders and the molecular genetics of familial and sporadic adrenocortical tumors and Cushing’s syndrome.

 

SENIOR EDITORS
 
Endocrinology of the Nervous System and Behaviour
Henrik Oster
University of Lübeck, Germany
Professor Oster is director of the Institute of Neurobiology at the University of Lübeck. After receiving his PhD in biochemistry in Fribourg (CH) and postdoctoral training in Hannover (DE) and Oxford (UK) he started his work in chronophysiology in Göttingen (DE) and, since 2011, in Lübeck (DE). His special interests are in the interaction of endocrine and circadian systems in the regulation of energy metabolism, behavioural functions, and sleep.
Jiang-Ning Zhou
University of Science and Technology of China
Jiang-Ning Zhou is Professor of Neurobiology at the University of Science and Technology of China, serving as head of of Key Laboratory of Brain Function and Brain Diseseas of the Chinese Academy of Sciences since 2009. He received a PhD in Neuroscience from the University of Amsterdam. His research interests is the neural circuit of corticotropin-releasing hormone neuron in stress and depression related behaviour. Jiang-Ning Zhou is a honorable member of the Chinese Neuroscience Society and the chair of the Neuroscience Society of Anhui Province. He has published more than 100 peer-reviewed publications as well as several books.
Endocrine-Disrupting Chemicals
Anna-Maria Andersson
Copenhagen University Hospital, Denmark
Dr Andersson is currently laboratory leader and research director at the Department of Growth and Reproduction, at the Copenhagen University Hospital. Her main research focuses are testicular function, especially the physiology and regulation of male reproductive hormones, including testosterone, inhibin B and Insl3. For the last 15–20 years one of her focus areas has been the impact of endocrine disrupting chemicals on hormone systems – with special focus on reproductive hormones, sex differentiation, pubertal development and male reproductive function.
Angel Nadal
Miguel Hernandez University of Elche, Spain
Professor of Physiology and Head of Unit at The Institute of Bioengineering at Miguel Hernández University of Elche, Alicante, Spain and Group Leader at CIBERDEM. He pioneered research linking endocrine disruptors and type 2 diabetes mellitus using cellular and animal models. His group works to understand the impact of estrogens and endocrine disruptors in the etiology of diabetes mellitus and related metabolic disorders. He is the Chair of the Endocrine Disrupting Chemicals Advisory Group of the Endocrine Society.
Adrenal
Felix Beuschlein
University Clinic Zurich, Switzerland
Felix Beuschlein is Professor of Internal Medicine/Endocrinology and Director of the Clinic for Endocrinology, Diabetology and Clinical Nutrition at the University Clinic Zurich in Switzerland. Following a professorship for Endocrine Research at the University of Munich he was recently elected to a chair position at the University of Zurich. His scientific interests mainly relate to adrenal disorders and endocrine tumors.
Massimo Terzolo
University of Turin – Internal Medicine at San Luigi Hospital, Italy
Professor Terzolo is director of the Division of Internal Medicine at San Luigi Hospital, and Full Professor of Internal Medicine at the University of Turin. Professor Terzolo is a clinical and translational researcher specialized on adrenal diseases with major expertise in management of patients with adrenal tumours. Recent work from his group has provided significant advances in the development of new therapeutic strategies for adrenal carcinoma and in the definition and management of subclinical Cushing syndrome.
Metabolic Syndrome and Diabetes
Sof Andrikopoulos
University of Melbourne, Australia
National Health and Medical Research Council of Australia (NH & MRC) Senior Research Fellow and head of the Islet Biology Research Group at the University of Melbourne Department of Medicine (Austin Health), which investigates the genetic susceptibility of islet dysfunction using animal models of diabetes.
Stefano Del Prato
Univeristy of Pisa, Italy
Professor Stefano Del Prato is Professor of Endocrinology and Metabolism at the School of Medicine, University of Pisa and Chief of the Section of Diabetes, University Hospital of Pisa, Italy. Professor Del Prato’s research interests have always been concerned with diabetes and, in particular, the physiopathology and therapy of type 2 diabetes and insulin resistance syndrome. He is a member of many societies and associations including the European Association for the Study of Diabetes, the American Diabetes Association, and the International Diabetes Federation. He has published over 400 articles in peer-reviewed international journals and has been awarded several honors.
Shashank Joshi
Lilavati and Bhatia Hospitals, India
Professor Joshi is the President of the Association of Physicians of India and President of the Indian Academy of Diabetes. He is a member of the faculty at Grant Medical College and the Sir JJ Group of Hospitals. Professor Joshi is a practicing endocrinologist and diabetologist at Lilavati and Bhatia Hospitals. He is a Fellow of the American College of Endocrinology, American College of Physicians and a Fellow of the Royal College of Physicians. Professor Joshi is actively involved with evidence-based work in endocrinology including diabetes, obesity, thyroid, osteoporosis and growth.
Xiaoping Luo
Tongji Hospital and Huazhong University of Science and Technology, China
Xiaoping Luo is Professor and Chairman of the Department of Pediatrics, Tongji Hospital, and Director of the Center for the Diagnosis of Genetic Metabolic Diseases, Tongji Medical College, Huazhong University of Science and Technology. His main interests are pediatric endocrine disorders, inherited metabolic diseases and neonatal medicine. He is now the Vice President of the Chinese Pediatric Society, President of the Chinese Society of Pediatric Endocrinology and Metabolism, and a standing committee member for the Chinese Society of Perinatal Medicine. He is also the past president for the Asian Pacific Pediatric Endocrine Society (APPES), and an Executive Committee member of Global Pediatric Endocrinology and Diabetes (GPED).
Valdis Pīrāgs
University of Latvia, Latvia
Valdis Pirags is Professor of Endocrinology and the Chair of Internal Medicine at the University of Latvia, and director of the Clinic of Internal Medicine at the Pauls Stradiņš Clinical University Hospital. Professor Pirags is credited with discovering of the PKC-dependent cellular mechanisms of platelet activation by glucose and revealing that probability of side effects of metformin are genetically predisposed. These research achievements resulted in establishing of a unique Laboratory of Personalised Medicine at his department. His current interests are focused on revealing of self-regulated psychoneuroendocrine mechanisms counteracting to pathogenesis and exacerbation of chronic diseases.
Hans Romijn
University of Amsterdam, The Netherlands
Currently Chairman of the Division of Medicine, Academic Medical Center, University of Amsterdam, The Netherlands. He served as president of the Dutch Endocrine Society from 2002–2006. His research interests include pathophysiology and the treatment of pituitary diseases and diabetes.
Cardiovascular
Adolfo de Bold
University of Ottawa Heart Institute
Professor de Bold is director of the Cardiovascular Endocrinology Laboratory at the Ottawa Heart Institute, and Professor of Pathology and Cellular and Molecular Medicine at the Unversity of Ottawa. Professor de Bold is credited with discovering atrial natriuretic peptide and revealing that the heart possesses an endocrine function.
Thyroid
Kristien Boelaert
University of Birmingham, UK
Kristien Boelaert is a Reader in Endocrinology at the University of Birmingham, UK. Her clinical and research interests include the management and consequences of thyroid dysfunction, the pathophysiology and management of thyroid nodules and cancer, the treatment of endocrine disorders in pregnancy and the consequences of iodine deficiency. Kristien has been the recipient of Visiting Clinician Fellowship at the Mayo Clinic, Rochester USA and of the Society for Endocrinology Young Clinical Endocrinologist Lectureship.
Denise Carvalho
Universidade Federal do Rio de Janeiro
Prof Carvalho is a Full Professor of Endocrine Physiology and chairman of the Endocrine Physiology Laboratory. She serves as the President of the Latin American Thyroid Society (LATS, 2015–2017), and was the Director of Carlos Chagas Filho Institute of Biophysics (2010–2013). Her research focuses on thyroid gland physiology and pathophysiology, mainly thyroid hormone biosynthesis, action and metabolism. Additional interests are related to translational studies regarding advanced thyroid cancer. More recently, she has participated in studies in the Amazonian Region and has begun the study of thyroid disorders associated to mercury, iron and selenium in the native populations of this Region.
Alicja Hubalewska-Dydejczyk
Jagiellonian University, Cracow, Poland
Professor Hubalewska-Dydejczyk is a specialist in internal medicine, endocrinology and nuclear medicine. Her major research interest is thyreology with special concerns in the management of thyroid dysfunction in pregnancy and in optimization the iodine prophylaxis in Europe. Since 1999 she works on optimization of diagnostic and therapeutic algorithm of neuroendocrine tumour patients including radioisotope imaging method and peptide receptor radionuclide therapy. Suprarenal glands and pituitary disorders are an additional area of interest.
Robert Rapaport
Mount Sinai School of Medicine, USA
Dr Rapaport is Professor of Pediatrics and Chief of the Division of Pediatric Endocrinology and Diabetes as well as the Program Director for the Fellowship Program at the Mount Sinai School of Medicine. He holds the Emma Elizabeth Sullivan Professor of Pediatric Endocrinology and Diabetes Chair at the Mount Sinai School of Medicine. His areas of expertise include growth, growth hormone, neonatal thyroid disease, childhood diabetes and pubertal disorders.
Bone and Mineral Metabolism
Martina Rauner
Technische Universitat Dresden, Germany
Dr Martina Rauner is the Scientific Director of the Bone lab of the Division of Endocrinology, Diabetes, and Bone Diseases at the Department of Medicine III, Medical Faculty of the Technische Universität Dresden. The lab is currently focusing on the role of the Wnt signaling pathway in the pathogeneses of metabolic, inflammatory, haematological, and malignant bone diseases.
Claudia Sedlinsky
Universidad Nacional de La Plata, Argentina
Claudia Sedlinsky is researcher at LIOMM, Laboratorio de Investigacion en Osteopatias y Metabolismo Mineral, devoted to issues like bone affection of diabetes mellitus and metabolic syndrome, the effects of advanced glycation end products on bone and vascular smooth muscle cells, and the action of different diabetes treatment agents on bone and VSMCs metabolism. As clinical endocrinologist she is in charge of the Bone and Mineral Metabolism Section of the Endocrine Unit of the Hospital Cesar Milstein.
Jennifer Walsh
University of Sheffield, UK
Jennifer Walsh is Senior Clinical Lecture at the University of Sheffield. Following competition of Medical School Dr Walsh trained in Endocrinology, and was awarded her PhD on Peak Bone Mass, funded by an ARUK Clinical Research Fellowship. Dr Walsh has a translational clinical research programme with current projects that include high-resolution pQCT imaging for bone microarchitecture, the interactions of fat and bone, vitamin D physiology, phenotyping of hypophosphatasia, and clinical trials of selenium in osteopenic women and testosterone in male cancer survivors.
Hormones and Cancer
Roderick Clifton-Bligh
University of Sydney, Australia
Currently Associate Professor at the University of Sydney, and Endocrinologist at Royal North Shore Hospital, Sydney, Australia. Professor Clifton-Bligh’s research interests are primarily in the genesis of endocrine tumours, including heritable syndromes. He also has a strong clinical and research interest in metabolic bone diseases.
Charis Eng
Sondra J and Stephen R Hardis Endowed Chair of Cancer Genomic Medicine, American Cancer Society Clinical Research Professor and Founding Chair of Cleveland Clinic's Genomic Medicine Institute, Cleveland, OH, USA
Professor Eng is a global leader in cancer genetics and cancer genomic medicine. She is an elected member of the Institute of Medicine of the US National Academies of Sciences and serves on a WHO Expert Panel on public health genomics. One of Professor Eng's areas of expertise is endocrine neoplasia genetics. Her work on RET testing in multiple endocrine neoplasia type 2, SDHx analysis in pheochromocytomas and paragangliomas, and characterization of the widening clinical spectra of PTEN mutations have been acknowledged as the paradigm for the practice of clinical cancer genetics.
Keely McNamara
Tohoku University, Sendai, Japan
Dr Keely McNamara has extensive experience in investigating various aspects of intracrine mechanisms of hormone dependent neoplasms in both prostate and breast. Following her PhD studies examining steroid metabolism in the prostate in mouse models of prostate neoplasia she moved to Japan first as a JSPS-AAS postdoctoral fellow and later as an Assistant Professor at Tohoku University. Her primary focus is translational research studying steroid metabolism and actions in the breast and in breast cancer.
Gail Risbridger
Monash University, Australia
Professor Risbridger is currently Deputy Dean Strategic Projects and leads the developments of Monash Comprehensive Cancer Consortium (MCCC) and Monash Partners Academic Health Science Centre. Professor Risbridger is the Research Director of MCCC and Chair, Faculty Research Centres & Institutes Committee. Professor Risbridger's research interests include the biology of stromal–epithelial cell interactions in normal and prostate cancer tumour tissue using tissue recombination, animal and human specimens. Professor Risbridger pioneered the use of stem cells for recombination studies combining stem cell biology with endocrinology. Other interests include endocrine disruption. Professor Risbridger's awards include an International Fulbright Senior Scholar Award, Society for Endocrinology Asia–Oceania Medal and Honorary Life Member of Endocrine Society of Australia.
Pituitary and Hypothalamus
Eduardo Arzt
University of Buenos Aires, Argentina
Professor Arzt is a member of the Research Scientific Career of the National Research Council of Argentina, Professor at the University of Buenos Aires, Visiting Professor at the Max Planck Institute of Psychiatry in Munich, Germany, External Scientific Member of the Max Planck Society and Director of the BioMedicine Institute of Buenos Aires – CONICET – a Partner Institute of the Max Planck Society. His interest is in the molecular biology of pituitary tumors and hormone production.
Charlotte Höybye
Karolinska University Hospital, Sweden.
Since 2001 Professor Höybye has been Senior Consultant in Endocrinology in the Department of Endocrinology, Metabolism and Diabetology, Karolinska University Hospital, Stockholm, Sweden and since 2004 has been Head of the Pituitary Section in the department. Her primary clinical and research interests are within the field of pituitary and hypothalamic diseases, including Prader–Willi Syndrome.
Jens Otto Lunde Jørgensen
Aarhus University Hospital, Denmark.
Professor and Chair of the Department of Clinical Medicine and the Department of Endocrinology and Diabetes. Professor Jørgensen’s main research interests include growth hormone (GH), GH-deficiency, metabolic actions of GH and acromegaly, with further work in insulin resistance states, obesity, Cushing, ghrelin.
Kok Onn Lee
National University of Singapore.
K O Lee is Professor at the National University of Singapore, and Consultant Endocrinologist at the National University Hospital in Singapore. His clinical interests are in Pituitary and Gonadal Endocrinology, and his research interests include the GH/IGF/IGFBP axis in fertility, and stem cells and gene therapy in Diabetes. He is a council member of the GH Research Society, and past president of the Endocrine and Metabolic Society of Singapore.
Agnes Linglart
Hôpital Bicêtre-Paris-Sud, France
Prof Linglart is a Paediatric Endocrinologist and Professor of Paediatrics. She is the Head of the French National Center of Reference for rare disorders of calcium and phosphorus metabolism and coordinates the network of physicians and molecular biologists working on these disorders. She is the current president of the french Society of Pediatric Endocrinology and Diabetology. Her clinical interests are in Paediatric Endocrinology and comprise Growth, Puberty, Adrenals, Pituitary and Bone diseases. Her research focuses on rare disorders of the mineral metabolism.
Reproduction
Claus Gravholt
University of Aarhus and Aarhus University Hospital, Denmark
Claus H Gravholt is Associate Professor at the University of Aarhus, and consultant in the Department of Endocrinology and in the Department of Molecular Medicine, Aarhus University Hospital. His clinical and research interests are sex hormone physiology and consequences of sex hormone deficiency as well as diabetesduring pregnancy and the effects hereof on the child. He is also studying the genetics of endocrine diseases, such as Turner and Klinefelter syndrome and 46,XY females, as well as the epidemiology of these diseases. He is a member of the European Society of Endocrinology, the US Endocrine Society.
STATISTICAL ADVISOR
 
Heather Whitaker
Open University, UK
Senior lecturer in Statistics at the Open University in the UK. She is a medical statistician with research interests in study design and applications in epidemiology, particularly pharmaco-epidemiology, vaccine safety, infectious diseases and environmental epidemiology. She is an expert in self-controlled study designs that are used to study the temporal association between acute outcomes and transient exposures. She studied at Sussex and Imperial College and teaches statistics by distance learning at the Open University.
 
 
EDITORIAL BOARD
O Ali USA T K Hansen Denmark E Søndergaard Denmark
C S Blesson USA X He USA K Stochholm Denmark
J Cantley Australia V Howell Australia G Sunil USA
D Chia USA N Krone UK W Winuthayanon USA
L Duranteau France R MacKenzie UK Q-E Yang USA
M E Grzesiak Poland A Pandey USA P M Yen USA
P Foster UK V Shah USA H Zhao USA
G Gravina Italy

Editors' declarations are listed in the journal's Disclosure Policy.